A Retrospective Cost-Benefit Analysis of Long-Acting Injectable Antipsychotics in Aggressive Patients at a Long-Term Inpatient Psychiatric Facility, Noor Daghistani, Jamie Silverberg, Jose A. Rey, Alexandra Perez
Alexandra Perez Rivera

A Retrospective Cost-Benefit Analysis of Long-Acting Injectable Antipsychotics in Aggressive Patients at a Long-Term Inpatient Psychiatric Facility, Noor Daghistani, Jamie Silverberg, Jose A. Rey, Alexandra Perez
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

A Retrospective Cost-Benefit Analysis of Long-Acting Injectable Antipsychotics in Aggressive Patients at a Long-Term Inpatient Psychiatric Facility, Noor Daghistani, Jamie Silverberg, Jose A. Rey, Alexandra Perez Rivera
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.

Invega Trinza: The First Four-Times-a-Year, Long-Acting Injectable Antipsychotic Agent, Noor Daghistani, Jose A. Rey
Faculty Articles